Medico Oncologo

Buenos Aires
Link de inscripción streamyard.com/watch/ifNEDPk… 👈
3
3
116
Rodrigo Sanchez Roger retweeted
Excellent timely table that encompasses the important perioperatives studies in MIBC. Copying our fellows as this will be a valuable, easy to use resource in the clinic! @RWinayak @vabreugoes @kor_shah @RodrigoFribourg
With VOLGA results coming at #ESMO26, a summary of contemporary phase III perioperative trials in muscle-invasive bladder cancer. ⚠️ Different populations and designs—avoid cross-trial comparisons. VOLGA and EV-303 importantly include surgery-alone control arms without neoadjuvant therapy. 🔑 The next challenge: identifying who truly needs adjuvant ADC therapy—and who can safely avoid it. #BladderCancer #GUOnc @OncoAlert @BladderCancerUS
2
16
69
3,978
Rodrigo Sanchez Roger retweeted
🧵 #ESMO26 prostate cancer highlights- my personal summary @urotoday:
1️⃣ Very high-risk localised: DASL-HiCaP & the ARPI class question
2️⃣ mHSPC: PEACE-1, CAPItello-281 OS + PSA >0.2: intensify or de-intensify? 
3️⃣ mCRPC: PROMPT, ctDNA vs tissue
4️⃣ NE PCa: KEYNOTE-365 1/5
2
29
57
4,248
Rodrigo Sanchez Roger retweeted
#ESMO26 Management of mCRPC: Personalized treatment selection and sequencing @dmukherji @urotoday Spectrum of PARPi sensitivity in mCRPC by HRR gene alteration Evidence from PROfound, MAGNITUDE, TALAPRO-2, PROpel, and FDA pooled analysis
1
40
84
3,760
Rodrigo Sanchez Roger retweeted
🇦🇷💯 Excelente charla (2) sobre “ Terapia de Deprivación Androgénica: Optimización del Tratamiento y su Impacto Metabólico” Dr. Federico FERRARIS"👏👏👏. 25º Curso Postgrado UroUNR. @sau_org @FFerraris_URO
2
2
4
138
Rodrigo Sanchez Roger retweeted
PROTEUS en #ESMO26: apalutamida + ADT perioperatoria vs prostatectomía sola en próstata de alto riesgo (n=408). 62% menos riesgo de evento, 51% menos de metástasis o muerte, 9 veces más respuesta patológica completa o mínima. #CáncerDePróstata. .
1
2
139
Rodrigo Sanchez Roger retweeted
#ESMO26: Detection of #ctDNA fractions with a single tumour-informed and tumour-agnostic profiling assay strongly predicted relapse and overall survival in a #LungCancer cohort from the #TRACERx programme 🔗 ow.ly/WhG05100nyY #InsightsbyESMO #NSCLC #LiquidBiopsy
5
6
1,620
Rodrigo Sanchez Roger retweeted
ESMO 2026 en Madrid: la oncología genitourinaria acelera hacia la precisión. Inmunoterapia perioperatoria, radioligandos alfa, ADCs de nueva generación y clasificadores genómicos. Desde hoy, serie con los hitos en próstata, vejiga, riñón y testículo. #ESMO26
1
1
134
Rodrigo Sanchez Roger retweeted
Devastating news —we were just #ESMO26 in Madrid. 42,000 people. I hope all our colleagues are safe going back from @myESMO …. Prayers for the victims and families. bbc.com/news/live/cv1j309d4g…
13
16
102
30,220
Rodrigo Sanchez Roger retweeted
For the moment part I, stay tuned the second one will follow soon!
@APCCC_Lugano 2026 Consensus is out! 😃🥳👩‍🔬👨‍⚕️ authors.elsevier.com/sd/arti… @Silke_Gillessen @AOmlin @oncodaily @INCMNSZ_Uronco @cdanicas @UroTeragLATAM High-risk localised and locally advanced PC 🔴 PSA recurrece & persistence 🟠 Neoadjuvant systemic therapy for RT & RP 🟢 Testosterone recover & supplementation 🔵 Genetic evaluation 🟣 Bone protection
1
6
29
1,422
Rodrigo Sanchez Roger retweeted
@APCCC_Lugano 2026 Consensus is out! 😃🥳👩‍🔬👨‍⚕️ authors.elsevier.com/sd/arti… @Silke_Gillessen @AOmlin @oncodaily @INCMNSZ_Uronco @cdanicas @UroTeragLATAM High-risk localised and locally advanced PC 🔴 PSA recurrece & persistence 🟠 Neoadjuvant systemic therapy for RT & RP 🟢 Testosterone recover & supplementation 🔵 Genetic evaluation 🟣 Bone protection
15
49
2,685
Rodrigo Sanchez Roger retweeted
DASL-HiCap trial #ESMO26 @myESMO @Silke_Gillessen @ANZUPtrials @APCCC_Lugano @oncodaily @OncoAlert 🔴ADT+Darolutamide+prostate/pelvis RT ⬆️ MFS-CI 🟠≠ definition "very high risk" & PSMA/PET not included 🟢Improved MFS-CI, PSA-PFS, CRPC, subsquent tx. But final analysis & OS awaited! 🔵3 studies: STAMPEDE, ENZARAD & DASL-HiCap. ≠ populations, ≠RT to pelvis, N1 benefit across trials. 🟣Good outcomes, need biomarkers
2
24
56
2,780
Rodrigo Sanchez Roger retweeted
*VOLGA study* cis-ineligible/refused @tompowles1 @MichvdHeijden @myESMO #ESMO26 @oncodaily @OncoAlert 🔴 EV+Durva x 3 w ⬆️ pCR, EFS, OS 🟠 ≈20% ❌ cystectomy 🟢 ct-DNA clearance associated w EFS 🔵 ⬆️ toxicity in triplet EV+Durva/T, will reduced dose impact oucomes? 🟣 Less migh be enough, more too much?
2
16
33
1,234
Rodrigo Sanchez Roger retweeted
Replying to @APCCC_Lugano
Superb meeting, superb people And in the most beautiful of settings. Strongly recommended
1
1
1
24
COME JOIN US in Lugano!! #LPCCC26 coming in Late April, Submit your abstracts NOW 👉 apccc.org/call-for-abstracts
Dear GU colleagues at #ESMO26! Dr Silke Gillessen & Dr. Aurelius Omlin🇨🇭 invite you to the inaugural LPCCC – Localised Prostate Cancer Consensus Conference! 🔬 CALL FOR ABSTRACTS NOW OPEN! 👉 Submit your abstract: apccc.org/call-for-abstracts 📅 LPCCC 2027 | 29 April – 1 May 2027 We invite colleagues in #ProstateCancer to submit their abstracts and contribute to shaping the discussion on the diagnosis and clinical management of men with localised prostate cancer. LPCCC marks an exciting new chapter for the APCCC family, extending the consensus-conference concept to localised disease, with a particular focus on areas where evidence, guidelines and clinical practice leave important questions unanswered. Two days of high-level presentations, expert discussion and debate will bring together the latest evidence and perspectives to address the questions that matter most in everyday clinical practice. We look forward to your contributions! #LPCCC27 #ProstateCancer #ESMO26 @APCCC_Lugano @BertrandTOMBAL @ChrisSweens1 @jmmrad @drjefstathiou @CaPsurvivorship @LoebStacy @charlesryanmd @AarmstrongDuke @Ecastromarcos @LVM_Walz @piet_ost @Nicola_Fossati @AnthonyMJoshua @Prof_Nick_James @VedangMurthy @AttardLab @Silke_Gillessen @AOmlin @ProfKHerrmann 📣 Also tagging: @AmandaNizamMD @scocmem @nataliagandur @gu_onc @tompowles1 @brian_rini @declangmurphy @cdanicas @neerajaiims
1
4
11
650
Rodrigo Sanchez Roger retweeted
Presidential symposium 1️⃣!! Interpath-001: adjuvant INT (intismeram) plus pembro impact in RFS & DMFS for stage II-IV resectable melanoma #ESMO26 @ProfGLongMIA @myESMO #personalizedmedicine
12
13
906
Rodrigo Sanchez Roger retweeted
Presidential symposium 1️⃣!! Volga trial: ph3 combo neoadjuvant EV + perioperative Durva +/- Treme. Dual primary endpoints of EFS were met. D+EV (HR 0.51) D+T+EV (HR 0.61) ❕#UrothelialCarcinoma #ESMO26 @myESMO @tompowles1 @FAndreMD
5
11
627
Rodrigo Sanchez Roger retweeted
Presidential symposium 1️⃣!! DeLLphi-305 study: Tarlatamab + durva significantly improved ✅ OS, PFS, and ORR ‼️ in 1LM ES-SCLC @myESMO #ESMO26 a 🆕 standard of care!
5
9
366
Rodrigo Sanchez Roger retweeted
Presidential symposium 1️⃣!! DASL-HCaP: Darolutamide significantly improved MFS-CI when added to ADT and loco-regional RT for very high-risk localised, or biochemically persistent/recurrent prostate cancer. #ESMO26 @myESMO
5
7
254
Rodrigo Sanchez Roger retweeted
Neither addition of HIF-2α inhibitor belzutifan nor of CTLA-4 blockade to pembrolizumab + lenvatinib in advanced #RCC improved efficacy; pembro + lenv remains a 1L SOC. By @DrChoueiri #ESMO26 @myESMO
3
12
301